• Global Business Expansion Buildup ① - Japan Market Trend Analysis and Global BD Success Cases 2026.08.25 (14:00 - 17:00) | E1 Seminar Room (Hall E) HekaBio K.K. Robert E. Claar CEO Detail View
  • US Regulations for Functional Types of Foods (Focused on NDI) 2026.08.26 (14:20∼15:10) | 3F Conference Room 317 BioFood Network Jin-Young K. Park, Consultants, BioFood Network Detail View
  • 317D

    닫기

    Title US Regulations for Functional Types of Foods (Focused on NDI)
    Date 2026.08.26 (14:20∼15:10) | 3F Conference Room 317
    Organization BioFood Network
    Speaker Jin-Young K. Park, Consultants, BioFood Network
    Speaker & Lecture Information

    [Brief Introduction of Seminar]

    The US Food and Drug Administration (FDA) regulates products marketed for physiological benefits under the Federal Food, Drug, and Cosmetic Act. These products are categorized based on their composition and intended use, rather than a distinct “functional food” category. Any novel component must meet one of two foundational premarket safety frameworks before entering interstate commerce.


    For conventional food matrices, added substances are legally considered unapproved food additives unless they achieve Generally Recognized as Safe (GRAS) status. A GRAS conclusion requires expert scientific consensus on safety under specific conditions of use, primarily relying on publicly available, peer-reviewed literature. Manufacturers can fulfill this requirement through an independent expert panel for a “Self-Affirmed GRAS” determination (that actively facing elimination and being replaced by mandatory notification) or voluntarily submit a formal dossier to the agency for official administrative closure.

    On the other hand, novel components engineered for dietary supplements rely on the New Dietary Ingredient (NDI) mechanism. This mechanism applies to any dietary ingredient not marketed in a supplement in the United States prior to October 15, 1994. If a substance lacks this historical market baseline, the manufacturer must file an electronic New Dietary Ingredient Notification (NDIN) to the FDA. This statutory mechanism mandates a strict 75-day premarket hold while the agency conducts its scientific safety evaluation. During this period, commercial distribution is legally blocked. Unlike the public data requirements of the GRAS pathway, an NDIN safety dossier can utilize confidential, proprietary toxicology data to demonstrate that the ingredient is reasonably expected to be safe under its proposed conditions of use.

     

    [Brief Introduction of Speaker]

    Ph.D. and MPH, Biologist/Regulatory Toxicologist from US FDA from 1998 to 2026 

  • US Regulations for Functional Types of Foods (Focused on NDI) 2026.08.26 (14:20∼15:10) | 3F Conference Room 317 BioFood Network Thane Scott Thurmond, Consultants, BioFood Network Detail View
  • The Changing Landscape of Health Consumption
    :Consumer Behavior Shifts and Emerging Directions in the Health Supplement Market
    2026.08.26 (15:50 - 16:30) | 3F Conference Room 317 NAVER Corporation Hyung meen Choi, Business Development Manager NAVER Shopping Detail View
  • Coupang’s Brand Protection Process and Growth Strategy for Healthy Food via Rocket Delivery 2026.08.26 (15:10 - 15:50) | 3F Conference Room 317 Coupang Inc. Sang pil Hong, Sr.Manager Detail View
  • Market Trends of Health Functional Foods in Korean Convenience Stores CU 2026.08.26 (14:20∼15:00) | 3F Conference Room 317 BGF Retail HWANG JI SEON, Team Manager Detail View
  • Growth and Trends of Health Foods on Kurly
    - Recent Trends in Health Foods on Kurly
    2026.08.26 (13:40 - 14:20) | 3F Conference Room 317 Kurly LEE HYUN YONG, Team Leader Detail View
  • 2026 Global Retail Trends & the Rise of Wellness 2026.08.26 (13:00 - 13:40) | 3F Conference Room 317 Retail Trend Lab YOON EUN YOUNG, Research Director Detail View
  • The Era of Japan's Foods with Function Claims (FFC): What Should You Prepare? 2026.08.26 (15:20∼16:10) | 3F Conference Room 317 Research Mentor Ohnuki Koichiro, Japan Regulatory Affairs Advisor Detail View